On Dec. 8, the U.S. Food and Drug Administration (FDA) cleared the Dignitana DigniCap Cooling System for marketing. The system reduces the frequency and severity of alopecia during chemotherapy in breast cancer patients. Read more.
© 2022 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.